drugset / Trial / NCT00494572
Montelukast With Status Asthmaticus, Ages 6-18
Phase 2/3
Unknown
52 enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Pediatric Pharmacology Research Units Network · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine if montelukast, in addition to standard treatment is helpful in treating patients ages 6-18 who are in the hospital because of status asthmaticus.
Timeline
- Start
- 2006-12
- Primary completion
- 2010-01
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montelukast | Other / unclassified | 10 mg | Oral |